You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 8, August 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS PRESENTED AT THE 99TH SCIENTIFIC SESSION OF THE WESTERN SURGICAL ASSOCIATION, COLORADO SPRINGS, COLO, NOVEMBER 15-18, 1991
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Transhiatal and Transthoracic Esophagectomy for Adenocarcinoma of the Esophagus

Marc R. Moon, MD; William J. Schulte, MD; George B. Haasler, MD; Robert E. Condon, MD

Arch Surg. 1992;127(8):951-955.


Abstract

• Adenocarcinoma of the esophagus is no longer rare and is treated by resection. To determine whether the approach used for resection influences outcome, we studied 88 patients who underwent resection; 14 had stage I or II disease, 74 had stage III, and 40 had stage IV. One third of those with Barrett's esophagus were noted on screening endoscopy to have potentially curable disease; the others were diagnosed with stage III or IV disease. Transhiatal esophagectomy was performed in 63 patients; 24 patients underwent transthoracic esophagectomy. We found no difference in survival or morbidity between transhiatal and transthoracic esophagectomy. Overall 5-year survival for stage I and II disease was 86%. For stage III and IV disease, 5-year survival was 14.5%. Aggressive surveillance of Barrett's esophagus facilitates the discovery of early disease. Esophagectomy for adenocarcinoma can result in cure of early cancers and improved palliation of more advanced disease.

(Arch Surg. 1992;127:951-955)



Author Affiliations

From the Department of Surgery, Medical College of Wisconsin, Milwaukee.


Footnotes

Accepted for publication March 7, 1992.

Presented at the 99th Scientific Session of the Western Surgical Association, Colorado Springs, Colo, November 19, 1991.

Reprint requests to Department of Surgery, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226 (Dr Schulte).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pulmonary complications after esophagectomy
Avendano et al.
Ann. Thorac. Surg. 2002;73:922-926.
ABSTRACT | FULL TEXT  

Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis
Hulscher et al.
Ann. Thorac. Surg. 2001;72:306-313.
ABSTRACT | FULL TEXT  

Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital
Macdonald et al.
Gut 1997;41:303-307.
ABSTRACT | FULL TEXT  

Laparoscopic Total Esophagectomy
Swanstrom and Hansen
Arch Surg 1997;132:943-949.
ABSTRACT  

A 15-Year Review of Esophagectomy for Carcinoma of the Esophagus and Cardia
Millikan et al.
Arch Surg 1995;130:617-624.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.